Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.04 USD | -1.74% | +5.54% | -1.68% |
05-09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
05-09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.68% | 222M | |
+7.61% | 115B | |
+12.72% | 107B | |
-13.44% | 22.31B | |
-3.99% | 21.6B | |
-6.59% | 18.23B | |
-39.93% | 17.62B | |
+6.79% | 14.26B | |
+32.92% | 12.37B | |
-27.78% | 8.28B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- INmune Bio : B. Riley Raises INmune Bio's PT to $32 from $26, Notes 'Encouraging' Datasets From 2 Lead Programs; Keeps Buy Rating